Compare TORM plc (TRMD) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TORM plc vs State Street SPDR S&P Biotech ETF — how do they compare? TORM plc trades at $29.89 (market cap $2.99B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: TORM plc pays a 9.62% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, TORM plc nearer its low. Which is the better fit depends on your goals.
| TRMD | XBI | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $34.87 | $164.28 |
52-Week Low | $17.50 | $85.16 |
Enterprise Value | $3.88B | — |
Dividend Yield | 9.62% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
